Do you want to read an article? Please log in or register.
Predictors of Mortality in Pulmonary Hypertension-Associated Chronic Lung Disease
Pulmonary Hypertension
RECOMMENDED
Related content
RECOMMENDED
COPDInterstitial Lung Disease
Pulmonary Rehabilitation and Functional Independence: Impact on Survival in Patients with Fibrotic Interstitial Lung Disease or Chronic Obstructive Pulmonary Disease
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Elmiger A, Marcin T, Bovet L, Brun P, Guler SA
doi: 10.1016/j.rmed.2024.107933
RECOMMENDED
AsthmaCOPDInterstitial Lung Disease
Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax
Whittaker H, Kramer Fiala Machado A, Hatam S, Cook S, Scully S, Evans HTT, Bolton T, Kallis C, Busby J, Heaney LG, Sheikh A, Quint JK, CVD-COVID-UK/COVID-IMPACT Consortium
doi: 10.1136/thorax-2024-222699
RECOMMENDED
Pulmonary Hypertension
Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Sci Rep
Smits AJ, Isebia K, Combee-Duffy C, van der Wal S, Nossent EJ, Boonstra A, Vonk-Noordegraaf A, Bogaard HJ, Serné EH
doi: 10.1038/s41598-024-69017-y
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Association Between Calcium Channel Blocker Use and the Risk of Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: A Longitudinal Cohort Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Jang HJ, Seong YM, Jeong J, Huh JY, Kim JH, Kim KH, Park JH, Choi WI
doi: 10.1016/j.rmed.2025.107939
RECOMMENDED
COPD
Use of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitor is Associated with reduced Emergency Room Visits and Hospitalization in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Diabetes Mellitus
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Shanmugavel Geetha H, Teo YX, Ravichandran S, Perkitt NR, Gogtay M, Lal A, Abraham GM, Trivedi N
doi: 10.1016/j.rmed.2024.107819
COPD
Associations of socioeconomic status and phenotypic frailty with incident chronic obstructive pulmonary disease: findings from UK Biobank participants
Chest
Feng Z, Li G, He Q, Sun N, Li T, Han Q, Zhao H, Ma Z, Sun M, Liu B, Wang Y, Lou Z, Ma S, Shi Y, Li J, Sun Z, Jiang M, Shen Y
doi: 10.1016/j.chest.2024.11.004
AsthmaCOPD
Burden of Respiratory Syncytial Virus Disease in Adults with Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Curr Allergy Asthma Rep
Penders Y, Brusselle G, Falsey AR, Rohde G, Betancur E, Guardado ME, Agudelo JLR, Saeedi P, Harrington L, Michaud JP
doi: 10.1007/s11882-025-01194-w
COPDEmphysema
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS)
Respir Med
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Dakin P, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM
doi: 10.1016/j.rmed.2024.107846
RECOMMENDED
Further Publications
Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Trudzinski FC, Jörres RA, Alter P, Watz H, Vogelmeier CF, Kauczor HU, Thangamani S, Debic M, Welte T, Behr J, Kahnert K, Bals R, Herr C, Heußel CP, Biederer J, von Stackelberg O, Fähndrich S, Wouters EFM, Waschki B, Rabe KF, Herth FJF, Palm V, COSYCONET study group
doi: 10.1186/s12931-024-02902-2